Perrigo launches generic scalp medicine

Drug launched under settlement with GlaxoSmithKline

ALLEGAN, Mich. — Drug maker Perrigo has launched a generic drug for treating problems of the scalp, the company said.

Perrigo announced the launch of clobetasol emulsion propionate foam in the 0.05% strength, a generic version of GlaxoSmithKline's Olux-E. The drug is used to treat moderate to severe dermatosis of the scalp.

As the first company to file a regulatory approval application for the drug, Perrigo is entitled to 180 days in which to compete exclusively with GlaxoSmithKline's version. The drug has annual sales of $38 million, according to Symphony Health Solutions.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Login or Register to post a comment.